keyword
https://read.qxmd.com/read/38641587/two-year-follow-up-of-a-clustered-randomised-controlled-trial-of-a-multicomponent-general-practice-intervention-for-people-at-risk-of-poor-health-outcomes
#21
JOURNAL ARTICLE
Richard L Reed, Leigh Roeger, Billingsley Kaambwa
BACKGROUND: This study was a two-year follow-up evaluation of health service use and the cost-effectiveness of a multicomponent general practice intervention targeted at people at high risk of poor health outcomes. METHODS: A two-year follow-up study of a clustered randomised controlled trial was conducted in South Australia during 2018-19, recruiting 1044 patients from three cohorts: children; adults (aged 18-64 years with two or more chronic diseases); and older adults (aged ≥ 65 years)...
April 19, 2024: BMC Health Services Research
https://read.qxmd.com/read/38641118/amendments-affect-the-community-assembly-and-co-occurrence-network-of-microorganisms-in-cd-and-pb-tailings-of-the-eucalyptus-camaldulensis-rhizosphere
#22
JOURNAL ARTICLE
Jiaqi Yang, Linnan Ouyang, Shaoxiong Chen, Chen Zhang, Jiaqi Zheng, Shae He
Mining tailings containing large amounts of Pb and Cd cause severe regional ecosystem pollution. Soil microorganisms play a regulatory role in the restoration of degraded ecosystems. The remediation of heavy metal-contaminated tailings with amendments and economically valuable Eucalyptus camaldulensis is a research hotspot due to its cost-effectiveness and sustainability. However, the succession and co-occurrence patterns of these microbial communities in this context remain unclear. Tailing samples of five kinds of Cd and Pb were collected in E...
April 17, 2024: Science of the Total Environment
https://read.qxmd.com/read/38641058/cost-effectiveness-of-axicabtagene-ciloleucel-for-adult-patients-with-relapsed-or-refractory-follicular-lymphoma-in-the-united-states
#23
JOURNAL ARTICLE
Olalekan O Oluwole, Markqayne D Ray, Katherine L Rosettie, Graeme Ball, Jorge Jacob, S Pinar Bilir, Anik R Patel, Caron A Jacobson
OBJECTIVES: The results of a recent single-arm trial (ZUMA-5) of axicabtagene ciloleucel (axi-cel) for relapsed/refractory (r/r) FL demonstrated high rates of durable response and tolerable toxicity among treated patients. To quantify the value of axi-cel compared to standard of care (SOC) to manage r/r FL patients who have had at least two prior lines of systemic therapy (3L+), a cost-effectiveness model was developed from a US third-party payer perspective. METHODS: A three-state partitioned survival cost-effectiveness model was developed with a lifetime horizon...
April 17, 2024: Value in Health: the Journal of the International Society for Pharmacoeconomics and Outcomes Research
https://read.qxmd.com/read/38641057/economic-evaluations-of-car-t-cell-therapies-for-hematologic-and-solid-malignancies-a-systematic-review
#24
REVIEW
Kednapa Thavorn, Emily Thompson, Srishti Kumar, Aliisa Heiskanen, Anubhav Agarwal, Harold Atkins, Risa Shorr, Terry Hawrysh, Kelvin Kar-Wing Chan, Justin Presseau, Daniel A Ollendorf, Ian D Graham, Jeremy M Grimshaw, Manoj Mathew Lalu, Surapon Nochaiwong, Dean A Fergusson, Brian Hutton, Doug Coyle, Natasha Kekre
OBJECTIVES: This study aims to systematically review evidence on the cost-effectiveness of chimeric antigen receptor (CAR)-T therapies for patients with cancer. METHODS: Electronic databases were searched in October 2022 and updated in September 2023. Systematic reviews, health technology assessments and economic evaluations that compared costs and effects of CAR-T therapy in cancer patients were included. Two reviewers independently screened studies, extracted data, synthesized results, and critically appraised studies using the Philips checklist...
April 17, 2024: Value in Health: the Journal of the International Society for Pharmacoeconomics and Outcomes Research
https://read.qxmd.com/read/38641056/validating-health-economic-models-with-the-probabilistic-analysis-check-dashboard-pacboard
#25
JOURNAL ARTICLE
Xavier G L V Pouwels, Karel Kroeze, Naomi van der Linden, Michelle M A Kip, Hendrik Koffijberg
OBJECTIVES: Health economic (HE) models are often considered as "black boxes" because they are not publicly available and lack transparency, which prevents independent scrutiny of HE models. Additionally, validation efforts and validation status of HE models are not systematically reported. Methods to validate HE models in absence of their full underlying code are therefore urgently needed to improve health policy making.This study aimed to develop and test a generic dashboard to systematically explore the workings of HE models and validate their model parameters and outcomes...
April 17, 2024: Value in Health: the Journal of the International Society for Pharmacoeconomics and Outcomes Research
https://read.qxmd.com/read/38640641/clinical-and-economic-burden-of-immune-tolerance-induction-in-entire-patients-with-hemophilia-a-insights-from-a-real-world-korean-setting
#26
JOURNAL ARTICLE
Ah-Young Kim, Hee Jo Baek, Sukhyang Lee, Eunjung Choo, Young Shil Park, Hankil Lee
INTRODUCTION: The most notable challenge facing hemophilia A treatment is the development of inhibitors against factor VIII, resulting in increased clinical and socioeconomic burdens due to the need for expensive bypassing agents (BPAs). Although immune tolerance induction (ITI) is currently the primary approach for inhibiting and reducing the inhibitors, the lengthy duration of ITI necessitates the continued use of BPA to manage bleeding episodes. In this study, we aimed to obtain real-world evidence on the clinical and economic aspects and associated burdens experienced by patients with hemophilia A with inhibitors undergoing ITI in Korea...
April 13, 2024: Thrombosis Research
https://read.qxmd.com/read/38640471/investigating-the-cost-effectiveness-of-telemonitoring-patients-with-cardiac-implantable-electronic-devices-systematic-review
#27
REVIEW
Sarah Raes, Andrea Prezzi, Rik Willems, Hein Heidbuchel, Lieven Annemans
BACKGROUND: Telemonitoring patients with cardiac implantable electronic devices (CIEDs) can improve their care management. However, the results of cost-effectiveness studies are heterogeneous. Therefore, it is still a matter of debate whether telemonitoring is worth the investment. OBJECTIVE: This systematic review aims to investigate the cost-effectiveness of telemonitoring patients with CIEDs, focusing on its key drivers, and the impact of the varying perspectives...
April 19, 2024: Journal of Medical Internet Research
https://read.qxmd.com/read/38640156/assessing-quality-of-life-economic-burden-and-independence-across-the-alzheimer-s-disease-continuum-using-patient-caregiver-dyad-surveys
#28
JOURNAL ARTICLE
Amir Abbas Tahami Monfared, Artak Khachatryan, Noemi Hummel, Agnieszka Kopiec, Marta Martinez, Raymond Zhang, Quanwu Zhang
BACKGROUND: Alzheimer's disease (AD) and mild cognitive impairment (MCI) have negative quality of life (QoL) and economic impacts on patients and their caregivers and may increase along the disease continuum from MCI to mild, moderate, and severe AD. OBJECTIVE: To assess how patient and caregiver QoL, indirect and intangible costs are associated with MCI and AD severity. METHODS: An on-line survey of physician-identified patient-caregiver dyads living in the United States was conducted from June-October 2022 and included questions to both patients and their caregivers...
April 16, 2024: Journal of Alzheimer's Disease: JAD
https://read.qxmd.com/read/38639988/healthcare-resource-utilization-and-associated-costs-in-patients-with-metastatic-urothelial-carcinoma-a-real-world-analysis-using-german-claims-data
#29
JOURNAL ARTICLE
Günter Niegisch, Marc-Oliver Grimm, Fraence Hardtstock, Julia Krieger, Alexandra Starry, Ulrike Osowski, Barthold Deiters, Ulf Maywald, Thomas Wilke, Mairead Kearney
AIMS: This retrospective claims data study characterized real-world treatment patterns, healthcare resource utilization (HCRU), and costs in patients with metastatic urothelial carcinoma (mUC) in Germany. MATERIALS AND METHODS: Continuously insured adults with incident mUC diagnosis (=index; ICD-10 : C65-C68/C77-C79) in 2015-2019 were identified from two German claims databases. Patients who received first-line (1 L) treatment within 12 months of index were divided into three mutually exclusive sub-cohorts: platinum-based chemotherapy (PB-CT), non-PB-CT, and immunotherapy (IO)...
2024: Journal of Medical Economics
https://read.qxmd.com/read/38639747/lymphoedema-specialists-embedded-into-community-nurse-and-wound-services-impacts-and-outcomes
#30
JOURNAL ARTICLE
Melanie Thomas, Karen Morgan, Ioan Humphreys
BACKGROUND: Lymphoedema is a progressive condition causing significant alterations to life, exerting pressures on unscheduled care from complications including cellulitis and wounds. An on the ground education programme (OGEP) was implemented to raise knowledge, competence and confidence in lymphoedema management in community clinical services. The aim of this study was to explore the impact and outcomes of the OGEP intervention. METHODS: Data were captured before and after OGEP on 561 lymphoedema patients in the community setting...
April 18, 2024: British Journal of Nursing: BJN
https://read.qxmd.com/read/38639672/challenges-and-opportunities-for-access-to-advanced-therapy-medicinal-products-in-brazil
#31
JOURNAL ARTICLE
Camile Giaretta Sachetti, Augusto Barbosa, Antonio Carlos Campos de Carvalho, Denizar Vianna Araujo, Everton Nunes da Silva
BACKGROUND AIMS: The marketing authorization of Advanced Therapy Medicinal Products (ATMPs) in Brazil is recent. The features of these therapies impose specialized regulatory action and are consequently challenging for developers. The goal of this study was to identify the industry's experience in clinical development, marketing authorization and access to ATMPs through the Unified Health System (SUS, acronym in Portuguese), from a regulatory perspective. METHODS: A survey containing structured questions was conducted among research participants who work at companies that commercialize ATMPs...
March 29, 2024: Cytotherapy
https://read.qxmd.com/read/38639473/exploring-practices-challenges-and-priorities-for-human-health-and-ecological-risk-assessments-in-indigenous-communities-in-canada
#32
JOURNAL ARTICLE
Katherine Chong, Gordon M Hickey, Hing Man Chan, Niladri Basu
Indigenous peoples in Canada are disproportionately exposed to environmental contaminants and may face elevated health risks related to their unique cultural, spiritual, and economic relationships with the land, including the use of traditional food systems. However, to date, institutionalized approaches to assess risks to human and ecological health from contaminants have not been well developed or implemented with Indigenous community contexts in mind. There is regulatory interest in developing new approach methods for risk assessment, and thus an opportunity to increase their relevance to Indigenous communities in which they will be ultimately applied...
April 19, 2024: Integrated Environmental Assessment and Management
https://read.qxmd.com/read/38639152/-physiotherapy-in-rehabilitation-of-patients-with-degenerative-disk-diseases-from-positions-of-evidence-based-medicine-a-literature-review
#33
JOURNAL ARTICLE
N F Miryutova, N G Badalov, N N Minchenko, N S Prilipko
UNLABELLED: Back pain is one of the most urgent problems of rehabilitation. Patients with this pathology have a leading place among neurological patients in terms of the number of days of disability. The high economic costs in society are explained by the need for lumbar surgery (discectomy, spinal fusion and disc prosthesis) and rehabilitation after it. The effectiveness of rehabilitative measures is determined both by the patient's rehabilitative potential and by the choice of rehabilitative methods...
2024: Voprosy Kurortologii, Fizioterapii, i Lechebnoĭ Fizicheskoĭ Kultury
https://read.qxmd.com/read/38639128/-anmco-scientific-statement-on-combination-therapies-and-polypill-in-secondary-prevention
#34
JOURNAL ARTICLE
Leonardo De Luca, Stefania Angela Di Fusco, Gianmarco Iannopollo, Raffaella Mistrulli, Vittoria Rizzello, Alberto Aimo, Alessandro Navazio, Claudio Bilato, Marco Corda, Massimo Di Marco, Giovanna Geraci, Attilio Iacovoni, Massimo Milli, Vittorio Pascale, Carmine Riccio, Pietro Scicchitano, Emanuele Tizzani, Domenico Gabrielli, Massimo Grimaldi, Furio Colivicchi, Fabrizio Oliva
The issue of suboptimal drug regimen adherence in secondary cardiovascular prevention presents a significant barrier to improving patient outcomes. To address this, the utilization of drug combinations, specifically single pill combinations (SPCs) and polypills, was proposed as a strategy to simplify treatment regimens. This approach aims to enhance treatment accessibility, affordability, and adherence, thereby reducing healthcare costs and improving patient health. The document is an ANMCO scientific statement on simplifying drug regimens for secondary cardiovascular prevention...
May 2024: Giornale Italiano di Cardiologia
https://read.qxmd.com/read/38638651/occupational-nerve-injuries-due-to-metallic-foreign-bodies-a-case-series-of-eighteen-patients
#35
JOURNAL ARTICLE
P Gupta, M Jindal, S Garg, K Garg
INTRODUCTION: Peripheral nerve injuries (PNIs) remain an important health problem. PNIs mostly affect young men as this age group is mostly involved in road traffic accidents and other injuries at workplace. PNI can occur from foreign bodies like metal chips while working in industries using lathe machines. Among PNI's, injuries to the ulnar nerve, the brachial plexus and the median nerve are the most frequent lesions encountered. MATERIALS AND METHODS: This presentation is on a series of 18 cases of nerve injuries among industrial workers located from finger level up to the arm excluding the brachial plexus due to metallic foreign bodies entering while operating lathe machines over a period of two years with patients being followed-up over a one year period...
March 2024: Malaysian Orthopaedic Journal
https://read.qxmd.com/read/38638098/the-indirect-costs-of-human-papillomavirus-related-cancer-in-central-and-eastern-europe-years-of-life-lost-and-productivity-costs
#36
JOURNAL ARTICLE
Ugne Sabale, Eugenia Karamousouli, Lazar Popovic, Zoárd Tibor Krasznai, Daniel Harrop, Anne Meiwald, Robert Hughes, Georgie Weston, Goran Bencina
BACKGROUND: Human papilloma virus (HPV) is a common cause of several types of cancer, including head and neck (oral cavity, pharynx, oropharynx, hypopharynx, nasopharynx, and larynx), cervical, vulval, vaginal, anal, and penile cancers. As HPV vaccines are available, there is potential to prevent HPV-related disease burden and related costs. METHOD: A model was developed for nine Central Eastern European (CEE) countries (Bulgaria, Croatia, Czechia, Hungary, Poland, Romania, Serbia, Slovakia, Slovenia)...
April 19, 2024: Journal of Medical Economics
https://read.qxmd.com/read/38637816/prevalence-and-differences-in-the-co-administration-of-drugs-known-to-interact-an-analysis-of-three-distinct-and-large-populations
#37
JOURNAL ARTICLE
Jon Sánchez-Valle, Rion Brattig Correia, Marta Camacho-Artacho, Rosalba Lepore, Mauro M Mattos, Luis M Rocha, Alfonso Valencia
BACKGROUND: The co-administration of drugs known to interact greatly impacts morbidity, mortality, and health economics. This study aims to examine the drug-drug interaction (DDI) phenomenon with a large-scale longitudinal analysis of age and gender differences found in drug administration data from three distinct healthcare systems. METHODS: This study analyzes drug administrations from population-wide electronic health records in Blumenau (Brazil; 133 K individuals), Catalonia (Spain; 5...
April 19, 2024: BMC Medicine
https://read.qxmd.com/read/38637754/an-economic-evaluation-of-eptinezumab-for-the-preventive-treatment-of-migraine-in-the-uk-with-consideration-for-natural-history-and-work-productivity
#38
JOURNAL ARTICLE
Edward Griffin, Gawain Shirley, Xin Ying Lee, Susanne F Awad, Alok Tyagi, Peter J Goadsby
BACKGROUND: Migraine is a highly prevalent neurological disease with a substantial societal burden due to lost productivity. From a societal perspective, we assessed the cost-effectiveness of eptinezumab for the preventive treatment of migraine. METHODS: An individual patient simulation of discrete competing events was developed to evaluate eptinezumab cost-effectiveness compared to best supportive care for adults in the United Kingdom with ≥ 4 migraine days per month and prior failure of ≥ 3 preventive migraine treatments...
April 18, 2024: Journal of Headache and Pain
https://read.qxmd.com/read/38637451/health-economics-in-a-world-of-uneconomic-growth
#39
JOURNAL ARTICLE
Martin Hensher, Gerry McCartney, Eleanor Ochodo
Multiple, accelerating and interacting ecological crises are increasingly understood as constituting a major threat to human health and well-being. Unconstrained economic growth is strongly implicated in these growing crises, and it has been argued that this growth has now become "uneconomic growth", which is a situation where the size of the economy is still expanding, but this expansion is causing more harm than benefit. This article summarises the multiple pathways by which uneconomic growth can be expected to harm human health...
April 18, 2024: Applied Health Economics and Health Policy
https://read.qxmd.com/read/38635524/improving-oral-health-and-related-health-behaviours-substance-use-smoking-diet-in-people-with-severe-and-multiple-disadvantage-a-systematic-review-of-effectiveness-and-cost-effectiveness-of-interventions
#40
JOURNAL ARTICLE
Laura J McGowan, Deepti A John, Ryan P W Kenny, Emma C Joyes, Emma A Adams, Hosein Shabaninejad, Catherine Richmond, Fiona R Beyer, David Landes, Richard G Watt, Falko F Sniehotta, Martha Paisi, Claire Bambra, Dawn Craig, Eileen Kaner, Sheena E Ramsay
BACKGROUND: People experiencing homelessness co-occurring with substance use or offending ('severe and multiple disadvantage' SMD) often have high levels of poor oral health and related health behaviours (particularly, substance use, smoking, poor diet). This systematic review aimed to assess the effectiveness and cost-effectiveness of interventions in adults experiencing SMD to improve oral health and related health behaviours. METHODS AND FINDINGS: From inception to February 2023, five bibliographic databases (MEDLINE, EMBASE, PsycINFO, CINAHL, and Scopus) and grey literature were searched...
2024: PloS One
keyword
keyword
57644
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.